Milan Shyam Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-05-2024
- Paid Up Capital ₹ 1.00 M
as on 22-05-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
About Milan Shyam Bio Sciences
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Srivastava, Sunita Srivastava, and Suresh Srivastava serve as directors at the Company.
- CIN/LLPIN
U24299UP2019PTC122716
- Company No.
122716
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Milan Shyam Bio Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Srivastava  | Director | 24-Oct-2019 | Current |
Sunita Srivastava  | Director | 24-Oct-2019 | Current |
| Suresh Srivastava | Director | 24-Oct-2019 | Current |
Financial Performance of Milan Shyam Bio Sciences.
Milan Shyam Bio Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Milan Shyam Bio Sciences?
Unlock access to Milan Shyam Bio Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Chem Genes India Private LimitedActive 22 years 5 monthsAjay Srivastava, Sunita Srivastava and 1 more are mutual person
Argosy Overseas Private LimitedActive 35 years 5 monthsSunita Srivastava and Suresh Srivastava are mutual person
- Ess Cee Biotech (India) Private LimitedActive 38 years 7 months
Sunita Srivastava and Suresh Srivastava are mutual person
- Magadh Avadh Chemical Industries Private LimitedActive 32 years 3 months
Suresh Srivastava is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Milan Shyam Bio Sciences?
Unlock and access historical data on people associated with Milan Shyam Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Milan Shyam Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Milan Shyam Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
